Charité intensifies cooperation with CLALIT Health Services

During the COVID-19 pandemic, Israel impressively demonstrated how efficient patient data collection can be used to advance research into the prevention of infections and development of therapies. One of Israel's largest healthcare organizations,…

4 Min
More

Multiple myeloma: Early detection of aggressive tumors

Berlin researchers and their partners describe how aggressive variants of multiple myeloma can be detected early. Their comprehensive study in “Nature Cancer” shows how changes in genetic material affect the protein profile of the tumor cells, and…

5 Min
More

Annual General Meeting of Eckert & Ziegler SE Approves Split-Off of Pentixapharm AG

The Annual General Meeting of Eckert & Ziegler SE (ISIN DE0005659700) today resolved to split-off Pentixapharm AG from Eckert & Ziegler SE and to distribute a dividend of EUR 0.05 per share for the 2023 financial year.

1 Min
More

3D maps of diseased tissues at subcellular precision

An open-source platform developed by researchers in Nikolaus Rajewsky’s lab at the Max Delbrück Center creates molecular maps from patient tissue samples with subcellular precision, enabling detailed study and potentially enhancing routine clinical…

3 Min
More

Eckert & Ziegler Subsidiary Pentixapharm Receives Encouraging FDA Feedback to Initiate Phase III Trial with PentixaFor as Radiopharmaceutical Diagnostic in Primary Aldosteronism

Pentixapharm AG, a radiopharmaceutical development company wholly owned by Eckert & Ziegler SE, today announced that it has received encouraging feedback from the U.S. Food and Drug Administration (FDA) following a recent Type C meeting with the…

3 Min
More

Berlin Center for Gene and Cell Therapies kicked off in Berlin

Berlin Center for Gene and Cell Therapies aspires to create a leading biotech ecosystem in Berlin / Federal Chancellor Scholz acknowledges the importance of the project for Germany / Governing Mayor of Berlin Kai Wegner assures support from the State…

9 Min
More

Novel Cancer Therapeutic from FMP Research enters clinical phase

Groundbreaking innovations by researchers at the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) provided the basis for the development of an antibody-drug conjugate (ADC) by the company Tubulis, which is now being used in a Phase I/IIa…

2 Min
More

MSD launches IDEA Studios in Berlin

IDEA Studios will be strategically located in Asian and European innovation hubs to partner closely with early-stage companies focused on improving patient care

5 Min
More

In severe COVID-19, neutrophils work overtime

Whether COVID-19 is mild or severe depends not only on how aggressive the coronavirus is, but also on the immune response of the infected individual. Using single-cell analyses, Berlin researchers have now identified two distinct molecular patterns…

4 Min
More

New perspectives for patients: National Strategy for Gene and Cell Therapies presented to the BMBF

Today, the Berlin Institute of Health at Charité (BIH) officially handed over the National Strategy for Gene and Cell Therapies to Federal Research Minister Bettina Stark-Watzinger (FDP). Some 150 experts from various stakeholder groups drew up the…

5 Min
More
Show more items